Nekrasov Mikhail Sergeyevich

Biography

2011: CEO of Nanolek

Since August 31, 2011 - General Director of the Russian biopharmaceutical company Nanolek.

2022: Full management of Nanolek with the departure of Vladimir Khristenko

Nanolek co-founder Vladimir Khristenko announced his resignation from the presidency, which he has held since 2015. This was announced on December 29, 2022 by Zdrav.Expert representatives of the Nanolek company. He transferred the full leadership of the pharmaceutical company - the supplier of 25% of vaccines for the national vaccination calendar of Russia - to his partner, General Director of Nanolek Mikhail Nekrasov. Read more here.

Being one of the co-founders of Nanolek, Mikhail Nekrasov remains its general director. One of the pioneers of the "new Russian pharma," a doctor by education and a successful entrepreneur in the field of biotechnology, he will continue to work on developing the company's business.

2023: Leaving the post of head of Nanolek

On May 17, 2023, representatives of the Nanolek company told Zdrav.Expert that its co-founder and former head Mikhail Nekrasov decided to leave his post and focus on scientific activities. His successor was Vladimir Nesterenko.

"I have long had a dream to engage in the development of a drug for the treatment of cancer, with the involvement of artificial intelligence. This is from the field of basic science, while in Nanolek we were engaged in applied projects with a significantly shorter time-to-market. Within the framework of real business, there is no time for scientific activity at all. In addition, I want to change the rhythm of work to a calmer one in order to pay more attention to my family and myself, - explained the reasons for his resignation Mikhail Nekrasov, one of the pioneers of the new Russian pharma, a doctor by education and general director of Nanolek from 2011 to 2023. - I leave the company in good hands and in stable condition. "